Publication

Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent stem cells

Ma, M. S., Kannan, V., de Vries, A. E., Czepiel, M., Wesseling, E., Balasubramaniyan, V., Kuijer, R., Vissink, A., Copray, S. & Raghoebar, G., Jan-2017, In : Journal of bone and mineral metabolism. 35, 1, p. 21-30 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent

    Final publisher's version, 1 MB, PDF document

DOI

New developments in stem cell biology offer alternatives for the reconstruction of critical-sized bone defects. One of these developments is the use of induced pluripotent stem (iPS) cells. These stem cells are similar to embryonic stem (ES) cells, but can be generated from adult somatic cells and therefore do not raise ethical concerns. Proper characterization of iPS-derived osteoblasts is important for future development of safe clinical applications of these cells. For this reason, we differentiated mouse ES and iPS cells toward osteoblasts using osteogenic medium and compared their functionality. Immunocytochemical analysis showed significant expression of bone markers (osteocalcin and collagen type I) in osteoblasts differentiated from ES and iPS cells on days 7 and 30. An in vitro mineralization assay confirmed the functionality of osteogenically differentiated ES and iPS cells. Gene expression arrays focusing on osteogenic differentiation were performed in order to compare the gene expression pattern in both differentiated and undifferentiated ES cells and iPS cells. We observed a significant upregulation of osteogenesis-related genes such as Runx2, osteopontin, collagen type I, Tnfsf11, Csf1, and alkaline phosphatase upon osteogenic differentiation of the ES and iPS cells. We further validated the expression of key osteogenic genes Runx2, osteopontin, osteocalcin, collagen type I, and osterix in both differentiated and undifferentiated ES and iPS cells by means of quantified real-time polymerase chain reaction. We conclude that ES and iPS cells are similar in their osteogenic differentiation capacities, as well as in their gene expression patterns.

Original languageEnglish
Pages (from-to)21-30
Number of pages10
JournalJournal of bone and mineral metabolism
Volume35
Issue number1
Publication statusPublished - Jan-2017

    Keywords

  • Osteoblasts, Osteogenesis, Induced pluripotent stem cells, Differentiation, Tissue engineering, IN-VITRO DIFFERENTIATION, ENGINEERING BONE TISSUE, OSTEOGENIC DIFFERENTIATION, ENDOCHONDRAL OSSIFICATION, TRANSCRIPTION FACTOR, GROWTH, GENE, MINERALIZATION, DEXAMETHASONE, REGENERATION

View graph of relations

ID: 28070580